IL103538A0 - Quinoxaline-carboxylic and-phosphonic acid derivatives - Google Patents
Quinoxaline-carboxylic and-phosphonic acid derivativesInfo
- Publication number
- IL103538A0 IL103538A0 IL103538A IL10353892A IL103538A0 IL 103538 A0 IL103538 A0 IL 103538A0 IL 103538 A IL103538 A IL 103538A IL 10353892 A IL10353892 A IL 10353892A IL 103538 A0 IL103538 A0 IL 103538A0
- Authority
- IL
- Israel
- Prior art keywords
- quinoxaline
- carboxylic
- acid derivatives
- phosphonic acid
- phosphonic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4135871A DE4135871A1 (en) | 1991-10-26 | 1991-10-26 | New quinoxaline derivs. |
DE4224200 | 1992-07-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL103538A0 true IL103538A0 (en) | 1993-03-15 |
IL103538A IL103538A (en) | 2001-07-24 |
Family
ID=25908683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10353892A IL103538A (en) | 1991-10-26 | 1992-10-25 | Quinoxaline-carboxylic and -phosphonic acid derivatives |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0565683A1 (en) |
JP (1) | JP3258008B2 (en) |
KR (1) | KR100262371B1 (en) |
CN (1) | CN1038840C (en) |
AU (1) | AU664212B2 (en) |
CA (1) | CA2099270A1 (en) |
CZ (1) | CZ286351B6 (en) |
FI (1) | FI932959A0 (en) |
HU (1) | HUT64756A (en) |
IL (1) | IL103538A (en) |
NO (1) | NO304693B1 (en) |
NZ (1) | NZ244896A (en) |
PL (1) | PL171125B1 (en) |
PT (1) | PT101004B (en) |
RU (1) | RU2117663C1 (en) |
SK (1) | SK281518B6 (en) |
WO (1) | WO1993008173A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK162491D0 (en) * | 1991-09-20 | 1991-09-20 | Novo Nordisk As | Heterocyclic compounds, their preparation and pharmaceutical preparations containing the compounds |
CA2138026C (en) * | 1992-06-22 | 2003-09-09 | Eckard Weber | Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists |
DE4314592A1 (en) * | 1993-04-28 | 1994-11-03 | Schering Ag | Benzo (f) quinoxalinedione derivatives, their production and use in medicinal products |
IL109397A0 (en) * | 1993-04-28 | 1994-07-31 | Schering Ag | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
DE4428152A1 (en) * | 1994-06-22 | 1996-01-04 | Basf Ag | New amido-quinoxalinediones, their production and use |
GB9419318D0 (en) * | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
ATE209644T1 (en) * | 1994-09-27 | 2001-12-15 | Yamanouchi Pharma Co Ltd | 1,2,3,4-TETRAHYDROQUINOXALINDIONE DERIVATIVES AND THEIR USE AS GLUTAMATE RECEPTOR ANTAGONISTS |
DE4439493A1 (en) * | 1994-10-25 | 1996-05-02 | Schering Ag | New quinoxalinedione derivatives, their production and use in pharmaceuticals |
DE4439492A1 (en) * | 1994-10-25 | 1996-05-02 | Schering Ag | New quinoxalinedione derivatives, their production and use in pharmaceuticals |
US6110911A (en) * | 1995-06-07 | 2000-08-29 | Warner-Lambert Company | Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
DE19521058A1 (en) * | 1995-06-09 | 1996-12-12 | Basf Ag | Process for the preparation of aromatic-containing polyether polyols |
DE19545251A1 (en) * | 1995-11-24 | 1997-05-28 | Schering Ag | New quinoxalinedione derivatives, their production and use in pharmaceuticals |
TW448171B (en) * | 1996-06-06 | 2001-08-01 | Yamanouchi Pharma Co Ltd | Imidazole-substituted quinoxalinedione derivatives |
DE19624808A1 (en) | 1996-06-21 | 1998-01-02 | Basf Ag | Pyrrolylquinoxalinediones, their preparation and use |
DE19728326A1 (en) * | 1997-06-27 | 1999-01-07 | Schering Ag | New quinoxalinedione derivatives, their production and use in pharmaceuticals |
US6015800A (en) * | 1997-09-03 | 2000-01-18 | Warner-Lambert Company | Substituted quinoxaline-2-ones as glutamate receptor antagonists |
EP0900567A3 (en) * | 1997-09-05 | 2001-05-02 | Pfizer Products Inc. | Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy |
IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
FR2769309B1 (en) | 1997-10-08 | 2001-06-15 | Oreal | KERATINIC FIBER OXIDATION DYE COMPOSITION COMPRISING AN AMINO ACID DERIVATIVE AS AN OXIDATION BASE AND NOVEL AMINO ACID DERIVATIVES |
GB0311406D0 (en) * | 2003-05-17 | 2003-06-25 | Queen Mary & Westfield College | Substituted phosphonate fluorescent sensors,and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0118982A1 (en) * | 1983-02-01 | 1984-09-19 | Sumitomo Chemical Company, Limited | Organic phosphorous quinoxalinone and their production and use |
NO179551C (en) * | 1987-11-10 | 1996-10-30 | Novo Nordisk As | Analogous Process for Preparing Therapeutically Effective Quinoxaline Compounds |
DK69790D0 (en) * | 1990-03-16 | 1990-03-16 | Novo Nordisk As | HETEROCYCLIC COMPOUNDS, THEIR PREPARATION OF USE |
-
1992
- 1992-10-23 PT PT101004A patent/PT101004B/en not_active IP Right Cessation
- 1992-10-25 CZ CZ19931387A patent/CZ286351B6/en not_active IP Right Cessation
- 1992-10-25 IL IL10353892A patent/IL103538A/en not_active IP Right Cessation
- 1992-10-25 SK SK727-93A patent/SK281518B6/en unknown
- 1992-10-25 JP JP50735393A patent/JP3258008B2/en not_active Expired - Fee Related
- 1992-10-25 HU HU9301877A patent/HUT64756A/en unknown
- 1992-10-25 PL PL92299929A patent/PL171125B1/en unknown
- 1992-10-25 CA CA002099270A patent/CA2099270A1/en not_active Abandoned
- 1992-10-25 AU AU28894/92A patent/AU664212B2/en not_active Ceased
- 1992-10-25 KR KR1019930701948A patent/KR100262371B1/en not_active IP Right Cessation
- 1992-10-25 EP EP92922676A patent/EP0565683A1/en not_active Withdrawn
- 1992-10-25 RU RU93044489A patent/RU2117663C1/en active
- 1992-10-25 WO PCT/DE1992/000895 patent/WO1993008173A1/en not_active Application Discontinuation
- 1992-10-26 CN CN92113338A patent/CN1038840C/en not_active Expired - Fee Related
- 1992-10-27 NZ NZ244896A patent/NZ244896A/en unknown
-
1993
- 1993-06-24 FI FI932959A patent/FI932959A0/en unknown
- 1993-06-25 NO NO932116A patent/NO304693B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SK72793A3 (en) | 1993-10-06 |
PL171125B1 (en) | 1997-03-28 |
NO932344L (en) | 1993-06-25 |
EP0565683A1 (en) | 1993-10-20 |
AU2889492A (en) | 1993-05-21 |
CN1038840C (en) | 1998-06-24 |
NO304693B1 (en) | 1999-02-01 |
KR930703271A (en) | 1993-11-29 |
NZ244896A (en) | 1995-07-26 |
JPH06503583A (en) | 1994-04-21 |
CZ138793A3 (en) | 1994-01-19 |
AU664212B2 (en) | 1995-11-09 |
JP3258008B2 (en) | 2002-02-18 |
PT101004A (en) | 1994-01-31 |
WO1993008173A1 (en) | 1993-04-29 |
FI932959A (en) | 1993-06-24 |
KR100262371B1 (en) | 2000-08-01 |
SK281518B6 (en) | 2001-04-09 |
RU2117663C1 (en) | 1998-08-20 |
HU9301877D0 (en) | 1993-09-28 |
NO932344D0 (en) | 1993-06-25 |
CZ286351B6 (en) | 2000-03-15 |
PT101004B (en) | 1999-10-29 |
HUT64756A (en) | 1994-02-28 |
PL299929A1 (en) | 1994-04-05 |
FI932959A0 (en) | 1993-06-24 |
CA2099270A1 (en) | 1993-04-27 |
CN1072929A (en) | 1993-06-09 |
IL103538A (en) | 2001-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0520277A3 (en) | 7-azaisoindolinyl-quinolone- and naphthyridoncarboxylic acid derivatives | |
AP9200447A0 (en) | Acetic acid derivatives | |
PH30227A (en) | 7-Isoindolinyl-quinolone-carboxylic acid derivatives | |
ZA94332B (en) | Quinolone- and naphtyridonecarboxylic acid derivatives | |
IL103538A0 (en) | Quinoxaline-carboxylic and-phosphonic acid derivatives | |
HU9203123D0 (en) | Substituted imidazolyl-propenic acid derivatives | |
ZA93190B (en) | Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives | |
AU646762B2 (en) | Cyclic-substituted imidazolyl-propenoic acid derivatives | |
HU9203124D0 (en) | Imidazolyl-propenic acid derivatives | |
HU9403116D0 (en) | Epoxy-succinic acid derivatives | |
ZA911398B (en) | Carboxylic acid derivatives | |
ZA929330B (en) | Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives. | |
ZA913132B (en) | Carboxylic acid derivatives | |
HU9302728D0 (en) | Pyridazinone-acetic acid derivatives | |
ZA941668B (en) | Acyloxyhexanoic acid derivatives | |
HU9300544D0 (en) | Sulfobenzyil-substituted imidazolyl-propane acid derivatives | |
AP9200396A0 (en) | Propenoic acid derivatives | |
ZA928275B (en) | Quinoxaline-carboxylic and -phosphonic acid derivatives. | |
IL110170A0 (en) | 2-Oximino-2-thienyl-acetic acid derivatives | |
ZA93125B (en) | Quinolone- and naphthyridone-carboxylic acid derivatives | |
ZA941923B (en) | Phenoxyphenylacetic acid derivatives | |
ZA922831B (en) | Novel thienyl-nonatetraenoic acid derivatives | |
HU9400588D0 (en) | 3-hydroxyanthranilic acid derivatives | |
ZA924932B (en) | 4-amino-3-hydroxycarboxylic acid derivatives | |
ZA922022B (en) | N-acyl-alpha-amino acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
RH1 | Patent not in force |